Kura Oncology
KURA
28 hedge funds and large institutions have $60.9M invested in Kura Oncology in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 3 closing their positions.
141% more capital invested
Capital invested by funds: $25.2M → $60.9M (+$35.7M)
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
12% more funds holding
Funds holding: 25 → 28 (+3)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$1.7M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$743K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$399K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$248K |
| 5 |
PPCM
Pillar Pacific Capital Management
Pacifica,
California
|
+$155K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$509K |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$391K |
| 3 |
MA
Minerva Advisors
Bala Cynwyd,
Pennsylvania
|
-$200K |
| 4 |
Goldman Sachs
New York
|
-$64K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$51.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RFA
26
Reilly Financial Advisors
La Mesa,
California
| $1K | +$1.01K | +200 | New |
|
|
27
Goldman Sachs
New York
| – | -$64K | -23,800 | Closed |
|
28
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$6.34K | -1,252 | -93% |
|
|
BJ
29
BlackRock Japan
Tokyo,
Japan
| – | -$3K | -1,204 | Closed |
|
|
BA
30
BlackRock Advisors
Wilmington,
Delaware
| – | -$2K | -768 | Closed |
|
31
Bank of America
Charlotte,
North Carolina
| – | -$1.26K | -248 | -80% |
|
KURA Hedge Fund Activity: Q3 2016 in Review
28 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q3 2016, worth a combined $60.9M — up 141% from $25.2M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new KURA positions and 3 closed out — a net gain of 3 holders — while 8 added to existing stakes and 8 trimmed.
The largest buyer was PFM Health Sciences, adding an estimated $1.7M. The largest seller was Boxer Capital, cutting an estimated $509K.
- 28 institutional investors held Kura Oncology (KURA) as of Q3 2016, up from 25 in Q2 2016.
- Funds reported $60.9M of Kura Oncology stock for Q3 2016, up 141% quarter-over-quarter.
- 6 funds opened new Kura Oncology positions in Q3 2016 and 3 closed out, a net change of +3 holders.
- The largest Kura Oncology buyer in Q3 2016 was PFM Health Sciences, an estimated $1.7M added.
- The largest Kura Oncology seller in Q3 2016 was Boxer Capital, an estimated $509K sold.
Based on aggregated 13F filings for Q3 2016.